Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 04, 2021

SELL
$4.33 - $6.63 $128,635 - $196,964
-29,708 Closed
0 $0
Q4 2020

Feb 01, 2021

SELL
$4.87 - $17.29 $5.77 Million - $20.5 Million
-1,185,198 Reduced 97.55%
29,708 $180,000
Q3 2020

Nov 09, 2020

BUY
$15.08 - $27.04 $4.46 Million - $8 Million
295,866 Added 32.19%
1,214,906 $20 Million
Q2 2020

Aug 07, 2020

SELL
$14.57 - $23.96 $5.62 Million - $9.24 Million
-385,655 Reduced 29.56%
919,040 $21.4 Million
Q1 2020

May 04, 2020

SELL
$10.27 - $21.23 $213,256 - $440,840
-20,765 Reduced 1.57%
1,304,695 $19.3 Million
Q4 2019

Feb 06, 2020

SELL
$8.36 - $23.81 $103,680 - $295,291
-12,402 Reduced 0.93%
1,325,460 $27.1 Million
Q4 2019

Feb 04, 2020

BUY
$8.36 - $23.81 $11.1 Million - $31.8 Million
1,333,491 Added 30507.69%
1,337,862 $23.5 Million
Q3 2019

Nov 12, 2019

BUY
$9.83 - $14.82 $42,966 - $64,778
4,371 New
4,371 $43,000
Q2 2019

Aug 15, 2019

SELL
$12.9 - $20.8 $7.25 Million - $11.7 Million
-562,399 Closed
0 $0
Q1 2019

May 03, 2019

BUY
$17.7 - $24.93 $557,373 - $785,045
31,490 Added 5.93%
562,399 $11.1 Million
Q4 2018

Feb 05, 2019

BUY
$19.05 - $36.45 $336,594 - $644,035
17,669 Added 3.44%
530,909 $12 Million
Q3 2018

Nov 01, 2018

BUY
$34.41 - $44.23 $13.7 Million - $17.6 Million
397,300 Added 342.68%
513,240 $19.1 Million
Q2 2018

Aug 02, 2018

SELL
$39.21 - $50.29 $260,354 - $333,925
-6,640 Reduced 5.42%
115,940 $4.55 Million
Q1 2018

May 04, 2018

BUY
$41.7 - $64.16 $3.71 Million - $5.7 Million
88,880 Added 263.74%
122,580 $6.02 Million
Q4 2017

Feb 01, 2018

BUY
$28.58 - $49.91 $338,101 - $590,435
11,830 Added 54.09%
33,700 $1.53 Million
Q3 2017

Oct 27, 2017

SELL
$23.08 - $34.92 $14,771 - $22,348
-640 Reduced 2.84%
21,870 $764,000
Q2 2017

Aug 07, 2017

BUY
N/A
22,510
22,510 $465,000

Others Institutions Holding ASMB

# of Institutions
1
Shares Held
16.3K
Call Options Held
0
Put Options Held
0

About ASSEMBLY BIOSCIENCES, INC.


  • Ticker ASMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,436,900
  • Market Cap $716M
  • Description
  • Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...
More about ASMB
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.